Confidential - Proprietary information of El-Vision Ltd. Contact: Mr. Arthur Rabner: 42 Ha-Rakevet Str, Tel-Aviv 67770, Israel Introducing Technology Preserving Sight for Everyone

Operation Started: Aug 2006 CEO: Mr. Tal Dilian CTO and Founder: Mr. Arthur Rabner Financing: About $1M (IL OCS, IL/US Private) Full Time Employees: 6 The Company 2

Ophthalmic Arena Bottlenecks 1. Underserved Populations (aging, diabetes, low awareness/income, remote areas) 2. Today Vision Screening services are not effective (mismatching ~30% - 60% of cases) 3. Tight Competition between Eye Care Professionals (50,000 in US ) 4. Tight Competition on High End Diagnostics Instruments Market (Total $1.5B in US, 10% growth) 3

Communication Link Eye Care office with plug-in El-Vision’s SW into EMR 4 Eye care assistant Patient under Test Examination is performed in an office or in any other place The Vision of Final Device The El-Vision Solution High-End Vision & Eyes Screening During 5 – 15 minutes All-In-One Device for

General ODs / OMDs El-Vision’s Opportunity Prescription Primary Eye Care Follow-up Special Eye Care Follow-up Low End (< $5K) Old Players Med Range (<$25K) Optometrists Ophthalmologists Old Players Startups High End: ( > $25K ) Specific Disease Experts Old Players Startups Leaders refer direct Vision Screeners Ophthalmic Assistants Preliminary exam delegate Users Population ================= Underserved Treated Leaders Competition High End: ( > $25K ) Optometrists Ophthalmologists Fight for customers El-Vision High End Vision & Eyes Screener Optometrists Ophthalmologists Ophthalmic Assistants delegate Treated Prompt Cheap Remote Comprehensive Vision & Eyes Screening Primary Care Physicians New Players Extended Audience More Optometrists Ophthalmologists specialization Special Eye Care Follow-up More Specific Disease Experts Increased Demand Manufacturers Instruments $1.5B/year in US 10% growth Users 50, ,000 Prescription Primary Eye Care Follow-up Leaders Sales Growth promotion 5

El-Vision: 12 months Milestones / Financials Prototype Clinical Studies Regulation Activities Funds Raising Proceeds Sep08Oct08Nov08Dec08Jan09Feb09Mar09Apr09May09Jun09Jul09Aug09 part1part2 VATest-rev3/4 $1M raising VATest Production Version VC/Corporate Funds Raising (round A) $120K$130K$120K$110K$100K$90K $60K$70K$50K $1,040,000 part3 (in US)part3 VATest FDA Application VATest-rev2 6

Thank you More detailed information is available, please contact the CTO of El-Vision, Arthur Rabner:

General ODs / OMDs Ophthalmic Diagnostic Arena Prescription Primary Eye Care Follow-up Special Eye Care Follow-up Low End (< $5K) Old Players Med Range (<$25K) Optometrists Ophthalmologists Old Players Startups High End: ( > $25K ) Specific Disease Experts Old Players Startups Leaders refer direct Vision Screeners Ophthalmic Assistants Preliminary exam delegate Users Population ================= Underserved Treated Challenges / Bottlenecks Leaders Low Sales High End: ( > $25K ) Fight for customers Optometrists Ophthalmologists Prescription Primary Eye Care Follow-up Opportunity El-Vision High End Vision & Eyes Screener Manufacturers Instruments Users